ELIQUENT Life Sciences Acquires RApport Global Strategic Services

January 22, 2024

ELIQUENT Life Sciences, a GHO Capital-backed global regulatory consultancy, has acquired UK-based RApport Global Strategic Services to expand its European regulatory capabilities. The deal adds RApport's European regulatory expertise to ELIQUENT's existing US and Asia Pacific capabilities, enabling enhanced end-to-end regulatory solutions for life sciences clients.

Buyers
ELIQUENT Life Sciences, GHO Capital Partners LLP
Targets
RApport Global Strategic Services
Platforms
ELIQUENT Life Sciences
Location
Surrey, United Kingdom
Transaction Type
Addon

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.